PowerShares Dynamic Pharmaceuticals ETF News

Sector ETF report for PJP

Solid earnings failed to impress pharma ETFs over the past month due to a broad sell-off in the market.

Smart Beta ETF report for PJP

Sector ETF report for PJP

Pharmaceuticals companies, even the old, large-cap variety, are innovators in their own right. They have to be.

Citadel Advisors LLC acquired a new stake in shares of Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 12,660 shares of the companys stock, valued at approximately $1,019,000. Citadel Advisors LLC owned about 0.23% of Invesco Dynamic Pharmaceuticals []

Morgan Stanley decreased its holdings in shares of Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) by 6.2% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 38,415 shares of the companys stock after selling 2,532 shares during the period. Morgan Stanley owned approximately 0.70% of Invesco Dynamic Pharmaceuticals ETF worth [] The post Morgan Stanley Sells 2,532 Shares of Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) appeared first on ETF Daily News .

Smart Beta ETF report for PJP

The S&P 500 Health Care Index is up 18% year-to-date, an admiral though not spectacular performance. While coronavirus vaccines remain a point of much discussion, pharmaceuticals stocks also fit the bill as solid though not spectacular. However, there are still reasons to consider exchange traded funds like the Invesco Dynamic Pharmaceuticals ETF (NYSEArca: PJP). PJP [] The post Economics, Patents Critical for Pharmaceuticals Innovation, Equity Prices appeared first on ETF Trends .

The S&P 500 Health Care Index is up 18% year-to-date, an admiral though not spectacular performance. While coronavirus vaccines remain a point of much discussion, pharmaceuticals stocks also fit the b

The slew of Q3 results has led to smooth trading in pharma ETFs over the past month.

Sector ETF report for PJP

The healthcare sector is getting its groove back, as a variety of exchange traded funds dedicated to the group are printing or residing near new highs. The Invesco Dynamic Pharmaceuticals ETF (NYSEArc

Many industry bigwigs reported solid results with some beating on earnings or revenues or both.

Upbeat earnings, COVID-19-related sales, compelling valuation and lucrative dividend prospects are boosting pharma and healthcare ETFs.